News
Zacks.com on MSN10h
MDGL Stock Soars 11% on New Patent Protecting Rezdiffra Dosing RightsMadrigal Pharmaceuticals stock jumps 11% after securing a new U.S. patent for Rezdiffra's dosing, reinforcing exclusivity ...
Zacks.com on MSN14h
Madrigal (MDGL) Moves 10.9% Higher: Will This Strength Last?Madrigal (MDGL) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate ...
Investor's Business Daily on MSN11h
Madrigal Pharmaceuticals Hits 80-Plus Relative Strength Rating BenchmarkMadrigal Pharmaceuticals shows improving price performance, earning an upgrade to its IBD Relative Strength Rating from 73 to 87.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback